Mortality in Hepatitis C Populations: Another Battle Against Drugs and Alcohol

In the era of efficacious and well-tolerated treatment for chronic hepatitis C virus (HCV) infection, there is an expanding population of individuals who achieve viral eradication. This in turn has generated a need to determine the impact of liver-related morbidity and mortality, particularly liver decompensation and hepatocellular carcinoma, in populations achieving sustained viral response (SVR), and how they correlate with that of the general population.